IMM

IMMUPHARMA PLC ORD 10P

TitleTime
Notice of AGM and posting of Report & AccountsThu 21/05/20 | 07:00
TR-1: Notification of major holdingsMon 18/05/20 | 13:45
Efforts in fight vs Covid-19 with Lupuzor; UrekaThu 14/05/20 | 07:00
Audited Report & Accounts published on websiteThu 30/04/20 | 09:57
FINAL RESULTS FOR THE 12M ENDED 31/12/19Thu 30/04/20 | 07:00
Holding(s) in CompanyFri 03/04/20 | 15:55
Holding(s) in CompanyThu 02/04/20 | 08:26
Second Price Monitoring ExtnTue 31/03/20 | 16:41
Price Monitoring ExtensionTue 31/03/20 | 16:37
Second Price Monitoring ExtnTue 31/03/20 | 12:07
Price Monitoring ExtensionTue 31/03/20 | 12:02
£1.5m Subscrip'n to fund R&D pipeline- replacementMon 30/03/20 | 08:02
Second Price Monitoring ExtnFri 20/03/20 | 16:45
Price Monitoring ExtensionFri 20/03/20 | 16:40
Second Price Monitoring ExtnWed 18/03/20 | 16:42
Price Monitoring ExtensionWed 18/03/20 | 16:37
Second Price Monitoring ExtnMon 16/03/20 | 16:43
Price Monitoring ExtensionMon 16/03/20 | 16:39
Price Monitoring ExtensionWed 04/03/20 | 16:35
Incanthera plc ? Admission to trading on NEXFri 28/02/20 | 07:03
Price Monitoring ExtensionFri 21/02/20 | 16:35
Incanthera announces Rule 23 Notice re NEX listingMon 17/02/20 | 08:00
Second Price Monitoring ExtnWed 12/02/20 | 16:41
Price Monitoring ExtensionWed 12/02/20 | 16:35
Update on the Avion AgreementThu 06/02/20 | 07:00
Second Price Monitoring ExtnWed 05/02/20 | 16:40
Price Monitoring ExtensionWed 05/02/20 | 16:35
Second Price Monitoring ExtnTue 07/01/20 | 16:40
Price Monitoring ExtensionTue 07/01/20 | 16:35
Price Monitoring ExtensionThu 19/12/19 | 16:35
Admission today to trading on Euronext GrowthThu 19/12/19 | 07:00
Publication of Information Note (Euronext Growth)Tue 17/12/19 | 07:00
Dual Listing on Euronext Growth BrusselsFri 13/12/19 | 07:00
Share Price VolatilityWed 11/12/19 | 12:49
TR-1: notification of major holdingsMon 02/12/19 | 07:00
Licence Agreement for Lupuzor with Avion in USThu 28/11/19 | 07:00
Second Price Monitoring ExtnMon 25/11/19 | 16:41
Price Monitoring ExtensionMon 25/11/19 | 16:35
Second Price Monitoring ExtnTue 05/11/19 | 16:41
Price Monitoring ExtensionTue 05/11/19 | 16:35
Second Price Monitoring ExtnMon 07/10/19 | 12:07
Price Monitoring ExtensionMon 07/10/19 | 12:02
Second Price Monitoring ExtnFri 04/10/19 | 12:07
Price Monitoring ExtensionFri 04/10/19 | 12:02
Second Price Monitoring ExtnTue 01/10/19 | 16:40
Price Monitoring ExtensionTue 01/10/19 | 16:35
Interim Results AnnouncementMon 30/09/19 | 07:00
Price Monitoring ExtensionWed 18/09/19 | 16:35
TR-1: notification of major holdingsThu 04/07/19 | 07:00
TR-1: notification of major holdingsTue 02/07/19 | 15:33
Update on LupuzorFri 28/06/19 | 07:00
2019 Annual General MeetingThu 27/06/19 | 13:38
Subscription to raise £2.66 millionWed 26/06/19 | 07:00
Notice of AGM and posting of Report & AccountsTue 04/06/19 | 07:00
FINAL RESULTSFri 24/05/19 | 07:00
Corporate Update - ReplacementTue 07/05/19 | 08:15
Corporate UpdateTue 07/05/19 | 07:00
Update on Nucant Cancer ProgrammeMon 01/04/19 | 07:00
Corporate UpdateThu 14/03/19 | 07:00
Clinical Development Collaboration with IncantheraMon 31/12/18 | 07:00
Second Price Monitoring ExtnFri 21/12/18 | 16:41
Price Monitoring ExtensionFri 21/12/18 | 16:36
Price Monitoring ExtensionThu 20/12/18 | 16:35
Appointment of Nominated AdviserMon 17/12/18 | 07:00
Update on Corporate ActivitiesFri 07/12/18 | 07:00
Second Price Monitoring ExtnThu 29/11/18 | 16:40
Price Monitoring ExtensionThu 29/11/18 | 16:35
Second Price Monitoring ExtnWed 28/11/18 | 16:40
Price Monitoring ExtensionWed 28/11/18 | 16:35
Second Price Monitoring ExtnFri 23/11/18 | 16:40
Price Monitoring ExtensionFri 23/11/18 | 16:35
Second Price Monitoring ExtnWed 21/11/18 | 16:40
Price Monitoring ExtensionWed 21/11/18 | 16:35
Price Monitoring ExtensionWed 07/11/18 | 16:35
Nominated Adviser StatusThu 01/11/18 | 13:38
Interim ResultsWed 26/09/18 | 07:00
Appointment of Joint BrokersWed 19/09/18 | 07:00
Corporate UpdateFri 07/09/18 | 07:00
Second Price Monitoring ExtnTue 10/07/18 | 16:40
Price Monitoring ExtensionTue 10/07/18 | 16:35
Result of AGMThu 28/06/18 | 12:16
Results of CIDP Pre-Clinical DataThu 14/06/18 | 07:00
Notice of AGM & Posting of Annual ReportWed 06/06/18 | 07:00
Update on Pivotal Phase III Trial of LupuzorTue 29/05/18 | 07:00
Final ResultsTue 29/05/18 | 07:00
Holding(s) in CompanyTue 24/04/18 | 11:59
Holding(s) in CompanyFri 20/04/18 | 08:24
Holding(s) in CompanyThu 19/04/18 | 08:05
Topline results of Lupuzor Pivotal Phase III TrialTue 17/04/18 | 07:00
Appointment of Joint BrokerWed 28/03/18 | 07:00
Lupuzor Pivotal Phase III Study UpdateFri 23/03/18 | 07:00
AIM Notice (17)Mon 05/03/18 | 16:13
Holding(s) in CompanyFri 09/02/18 | 14:00
Holding(s) in CompanyWed 07/02/18 | 09:35
Holding(s) in CompanyMon 05/02/18 | 07:00
Holding(s) in CompanyWed 31/01/18 | 10:23
Successful Placing to Raise £10 MillionWed 24/01/18 | 07:00
Completion of LupuzorT Pivotal Phase III StudyThu 18/01/18 | 07:00
Grant of OptionsThu 21/12/17 | 07:05
Last patient completes dosing in LupuzorT TrialThu 21/12/17 | 07:00
Holding(s) in CompanyTue 28/11/17 | 12:00
Grant of OptionsFri 24/11/17 | 13:32
Update on LupuzorT Pivotal Phase III StudyThu 02/11/17 | 07:00
Holding(s) in CompanyMon 16/10/17 | 15:29
Completion of Lanstead Sharing AgreementWed 04/10/17 | 07:00
Interim ResultsWed 27/09/17 | 07:00
Preparation of Lupuzor'sT Regulatory SubmissionsTue 26/09/17 | 07:00
Update on LupuzorT Pivotal Phase III StudyThu 21/09/17 | 07:00
Notification of Interim ResultsTue 19/09/17 | 07:00
AIM Rule 17 NoticeFri 18/08/17 | 17:09
Grant of OptionsWed 12/07/17 | 11:00
Result of AGMFri 30/06/17 | 12:04
Update on LupuzorT Pivotal Phase III StudyFri 30/06/17 | 07:00